Even though peers were trading 70-100 million market caps after pre clinical success the Share price will rerate and multi bag in a day leading from GLP to Walter Reed and phase 1 completion, leading to phase 2 and into FDA phase 2 which the company is fully funded. Big quarter ahead and the directors have filled themselves up which shows you the confidence.
Let the news flow fall shortly
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-170
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.43M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.0¢ | $245.6K | 829.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29101 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 311729 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |